Skip to main content

A phase 2 randomized, open-label, parallel group study to assess the immunogenicity, safety, and tolerability of Moderna mRNA-1273 vaccine administered with casirivimab+imdevimab in healthy adult volunteers

Research Grant
Duke Scholars

Administered By

Surgery, Surgical Sciences

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

August 20, 2021

End Date

February 28, 2023
 

Administered By

Surgery, Surgical Sciences

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

August 20, 2021

End Date

February 28, 2023